Literature DB >> 15602658

Functional consequences of IGFBP excess-lessons from transgenic mice.

Eckhard Wolf1, Marlon R Schneider, Rui Zhou, Thomas M Fisch, Nadja Herbach, Maik Dahlhoff, Rüdiger Wanke, Andreas Hoeflich.   

Abstract

The functions of insulin-like growth factor-binding proteins (IGFBPs) have been studied extensively in vitro, revealing IGF-dependent and also IGF-independent effects on cell growth, differentiation, and survival. In contrast, the biological relevance of IGFBPs in vivo is only partially understood. In the past decade, mouse models lacking or overexpressing specific IGFBPs have been generated by transgenic technology. Phenotypic analysis revealed features that are common for most IGFBPs (growth inhibition), but also effects that appear to be specific for some but not all IGFBPs, such as disturbed glucose homeostasis (IGFBP-1 and -3) or impaired fertility (IGFBP-1, -5, and -6). Future systematic comparison of IGFBP functions in transgenic mice will be facilitated by targeted insertion of IGFBP expression vectors and by standardized phenotype assessment. Furthermore, analysis of IGFBP expression in growth-selected mouse lines or pedigrees segregating for growth phenotypes will be important to understand the roles of IGFBPs in multigenic growth regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15602658     DOI: 10.1007/s00467-004-1657-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  65 in total

1.  Bone formation in the context of growth retardation induced by hIGFBP-1 overexpression in transgenic mice.

Authors:  N Ben Lagha; P Menuelle; D Seurin; M Binoux; Y Lebouc; A Berdal
Journal:  Connect Tissue Res       Date:  2002       Impact factor: 3.417

2.  Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia.

Authors:  J Wang; W Niu; D P Witte; S D Chernausek; Y E Nikiforov; T L Clemens; B Sharifi; A R Strauch; J A Fagin
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

3.  Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.

Authors:  K Rajkumar; M Krsek; S T Dheen; L J Murphy
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

4.  Insulin-like growth factor-I influences the initiation of myelination: studies of the anterior commissure of transgenic mice.

Authors:  P Ye; J Carson; A J D'Ercole
Journal:  Neurosci Lett       Date:  1995-12-15       Impact factor: 3.046

5.  Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice.

Authors:  J V Silha; Y Gui; T Modric; A Suwanichkul; S K Durham; D R Powell; L J Murphy
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

Review 6.  Derangements of the somatotropic hormone axis in chronic renal failure.

Authors:  B Tönshoff; W F Blum; O Mehls
Journal:  Kidney Int Suppl       Date:  1997-03       Impact factor: 10.545

7.  Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1.

Authors:  S Doublier; D Seurin; B Fouqueray; M C Verpont; P Callard; L J Striker; G E Striker; M Binoux; L Baud
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

8.  Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.

Authors:  P A Crossey; J S Jones; J P Miell
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia.

Authors:  R D Devlin; Z Du; V Buccilli; V Jorgetti; E Canalis
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

10.  Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.

Authors:  Josef V Silha; Suresh Mishra; Clifford J Rosen; Wesley G Beamer; Russell T Turner; David R Powell; Liam J Murphy
Journal:  J Bone Miner Res       Date:  2003-10       Impact factor: 6.741

View more
  6 in total

Review 1.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

2.  PAPPA2, an enzyme that cleaves an insulin-like growth-factor-binding protein, is a candidate gene for a quantitative trait locus affecting body size in mice.

Authors:  Julian K Christians; Andreas Hoeflich; Peter D Keightley
Journal:  Genetics       Date:  2006-05-15       Impact factor: 4.562

3.  Insulin-like growth factor binding protein-7 induces activation and transdifferentiation of hepatic stellate cells in vitro.

Authors:  Li-Xin Liu; Shuai Huang; Qian-Qian Zhang; Yi Liu; Dong-Mei Zhang; Xiao-Hong Guo; De-Wu Han
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

4.  RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium.

Authors:  Angela F Messmer-Blust; Melissa J Philbrick; Shuzhen Guo; Jiaping Wu; Ping He; Shaodong Guo; Jian Li
Journal:  Circ Res       Date:  2012-07-25       Impact factor: 17.367

5.  Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.

Authors:  Arne Hinrichs; Barbara Kessler; Mayuko Kurome; Andreas Blutke; Elisabeth Kemter; Maren Bernau; Armin M Scholz; Birgit Rathkolb; Simone Renner; Sebastian Bultmann; Heinrich Leonhardt; Martin Hrabĕ de Angelis; Hiroshi Nagashima; Andreas Hoeflich; Werner F Blum; Martin Bidlingmaier; Rüdiger Wanke; Maik Dahlhoff; Eckhard Wolf
Journal:  Mol Metab       Date:  2018-03-15       Impact factor: 7.422

6.  Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5.

Authors:  Xinh-Xinh Nguyen; Matthew Sanderson; Kristi Helke; Carol Feghali-Bostwick
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.